http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102532126-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af121e2320f1b2cc3010325ae9e3ada6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate | 2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fbe4e8f0a637a277b1ecb8083e493b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f03526ec4141aa53343c4f77d3dba3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b9ade6e4d598e0eadf01d593798594d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_675b12f97334e2c250745053a90481e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce06db8dc06e84622e8b8a58e31b295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a98b3c561fdcb24aaaf8fd2b1261bbe4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95d8d7512045424e2f7ba7717eccbe5 |
| publicationDate | 2014-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102532126-B |
| titleOfInvention | 2-substituted-4-chloro-5-[5-subtsituted amino-2-(1,3,4-thiadiazole)-sulfydryl]-3(2H)- pyridazinone derivatives, and preparation method and application thereof |
| abstract | The invention discloses 2-substituted-4-chloro-5-[5-subtsituted amino-2-(1,3,4-thiadiazole)-sulfydryl]-3(2H)- pyridazinone derivatives, and a preparation method and application thereof. The structure of the compounds is shown as a general formula (I). A series of tertiary butyl pyridazinone compounds containing 1,3,4-thiadiazole are synthesized by taking mucochloric acid, substituted hydrazine, substituted aniline (fatty amine), carbon disulfide, ethyl chloroformate, 80 percent hydrazine hydrate and the like as raw materials through the steps of addition, substitution, hydrazinolysis, cyclization, and nucleophilic substitution. The compounds can be used for preparing anti-cancer medicines. |
| priorityDate | 2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.